Clinical Study | Office of Clinical Research

Hiv Prevention Study

Posted Date: Jun 17, 2021

Investigator: Moises Huaman Joo
Specialties:
Type of Study: Drug

A Phase 3, Double-Blind, Multicenter, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous Twice Yearly Long-Acting Lenacapavir for HIV Pre-Exposure Prophylaxis in Cisgender Men, Transgender Women, Transgender Men, and Gender Non-binary People = 16 Years of Age who Have Sex with Male Partners and are at Risk for HIV Infection

Criteria:

Null

Keywords:

Hiv, Prevention

For More Information:

Sharon Kohrs, Rn
513-584-6383
kohrssd@ucmail.uc.edu

Name*
First Last
Gender*
- Male
- Female
Age*
Phone*
Email*
How did you hear about us?*
Future Communication*
- By submitting this form, I am agreeing to receive future communication about participating in an upcoming research study.
CAPTCHA
This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.
List